🔴 Tempus AI is trading 4.4% down today amid broader tech and AI sector pressure

Tempus AI is trading 4.4% down at $54.71 today amid broader pressure on technology and AI-related stocks.

• The Nasdaq Composite is trading lower, weighing on high-growth AI names and the broader technology sector.
• The company recently highlighted the ARTICULATE PRO study, which demonstrated the successful real-world deployment of its Paige Prostate AI Suite in the UK’s NHS.
• While the study showcases clinical success for Tempus-linked tools, the publication has not been clearly tied by sources to today’s share-price move.